Page 2 of 2
Quest consistently spends about 20 percent of its revenue on research and development, and plans to continue doing so after the BakBone acquisition closes. "It's in the DNA of our company," he said.
Quest did extensive due diligence before unveiling the proposed acquisition, and Eberling said BakBone will bring his company not only people who developed BakBone's technology, but who are passionate about it.
He is also aware that BakBone might have irked partners in the past with its sales strategy.
"I know [BakBone] at one time decided to go direct," he said. "That might have alienated some partners."
BakBone brings Quest about 600 partners, while Quest's current main backup product, vRanger, has about 2,400 partners. Eberling said Quest will be looking at how to bring the two channels and product lines together over the next 90 days.
"By the time the deal closes, we expect to have a great promise to meet with our roadmap," he said. "And when we make a promise, we keep it."
<< Previous
|
1
|
2
